Smaller CHIP clones (under 10% VAF) were specifically associated with prevalent RA in the FINRISK cohort; however, only three participants with prevalent RA had CHIP clones with more than 10% VAF. This evidence concerns the gene STUB1 and rheumatoid arthritis.